C9142 – Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

Long description

Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg

Short description

Inj, alymsys, 10 mg

Pricing indicator

53 Statute

Medicare coverage

D Special coverage instructions apply

BETOS category

O1E Other drugs

Added

October 1, 2022

Last change

January 1, 2023 – No change

Termination date

December 31, 2022

Nearby C codes

• C9134 – Factor xiii (antihemophilic factor, recombinant), tretten, per 10 i.u.
• C9135 – Factor ix (antihemophilic factor, recombinant), alprolix, per i.u.
• C9136 – Injection, factor viii, fc fusion protein, (recombinant), per i.u.
• C9137 – Injection, factor viii (antihemophilic factor, recombinant) pegylated, 1 i.u.
• C9138 – Injection, factor viii (antihemophilic factor, recombinant) (nuwiq), 1 i.u.
• C9139 – Injection, factor ix, albumin fusion protein (recombinant), idelvion, 1 i.u.
• C9140 – Injection, factor viii (antihemophilic factor, recombinant) (afstyla), 1 i.u.
• C9141 – Injection, factor viii, (antihemophilic factor, recombinant), pegylated-aucl (jivi), 1 i.u.
• C9143 – Cocaine hydrochloride nasal solution (numbrino), 1 mg
• C9144 – Injection, bupivacaine (posimir), 1 mg
• C9145 – Injection, aprepitant, (aponvie), 1 mg
• C9146 – Injection, mirvetuximab soravtansine-gynx, 1 mg
• C9147 – Injection, tremelimumab-actl, 1 mg
• C9148 – Injection, teclistamab-cqyv, 0.5 mg
• C9149 – Injection, teplizumab-mzwv, 5 mcg
• C9150 – Xenon xe-129 hyperpolarized gas, diagnostic, per study dose